BRIEF-Alvotech And Teva Announce Filing Acceptance Of U.S. Biologics License Application

Reuters
18 Feb
BRIEF-<a href="https://laohu8.com/S/ALVO">Alvotech</a> And Teva Announce Filing Acceptance Of U.S. Biologics License Application

Feb 18 (Reuters) - Alvotech SA ALVO.O:

  • ALVOTECH AND TEVA ANNOUNCE FILING ACCEPTANCE OF U.S. BIOLOGICS LICENSE APPLICATION FOR AVT06, A PROPOSED BIOSIMILAR TO EYLEA® (AFLIBERCEPT)

  • ALVOTECH SA - REGULATORY APPROVAL EXPECTED BY Q4 2025

  • ALVOTECH SA - FDA ACCEPTS FOR REVIEW BLA FOR ALVOTECH'S BIOSIMILAR TO EYLEA

Source text: ID:nGNX6fMNSN

Further company coverage: ALVO.O

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10